Related Experiment Video
Updated: May 3, 2026
![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)
Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA
Published on: December 19, 2019
TMPRSS4 induces cancer cell invasion through pro-uPA processing
Hye-Jin Min1, Myung Kyu Lee2, Jung Weon Lee3
1Immunotherapy Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejon, Republic of Korea.
Abstract:
TMPRSS4 is a novel type II transmembrane serine protease that is highly expressed on the cell surface in pancreatic, thyroid, colon, and other cancer tissues. Previously, we demonstrated that TMPRSS4 mediates cancer cell invasion, epithelial-mesenchymal transition, and metastasis and that increased TMPRSS4 expression correlates with colorectal cancer progression. We also demonstrated that TMPRSS4 upregulates urokinase-type plasminogen activator (uPA) gene expression to induce cancer cell invasion. However, it remains unknown how proteolytic activity of TMPRSS4 contributes to invasion. In this study, we report that TMPRSS4 directly converted inactive pro-uPA into the active form through its proteolytic activity. Analysis of conditioned medium from cells overexpressing TMPRSS4 demonstrated that the active TMPRSS4 protease domain is released from the cells and is associated with the plasma membrane. Furthermore, TMPRSS4 could increase pro-uPA-mediated invasion in a serine proteolytic activity-dependent manner. These observations suggest that TMPRSS4 is an upstream regulator of pro-uPA activation. This study provides valuable insights into the proteolytic function of TMPRSS4 as well as mechanisms for the control of invasion.
Insights
Transmembrane serine protease 4 (TMPRSS4) activates pro-urokinase-type plasminogen activator (pro-uPA), driving cancer invasion. This study reveals TMPRSS4
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- TMPRSS4 is a type II transmembrane serine protease highly expressed in various cancers, including pancreatic, thyroid, and colon.
- Previous studies linked TMPRSS4 to cancer cell invasion, epithelial-mesenchymal transition, metastasis, and colorectal cancer progression.
- TMPRSS4 was shown to upregulate urokinase-type plasminogen activator (uPA) gene expression, promoting cancer cell invasion.
Purpose of the Study:
- To investigate the role of TMPRSS4's proteolytic activity in cancer cell invasion.
- To determine if TMPRSS4 directly activates pro-uPA.
- To elucidate the upstream regulatory mechanisms of pro-uPA activation by TMPRSS4.
Main Methods:
- Analysis of conditioned medium from cells overexpressing TMPRSS4.
- Assessing the association of the active TMPRSS4 protease domain with the plasma membrane.
- Investigating the effect of TMPRSS4 on pro-uPA-mediated invasion in a serine proteolytic activity-dependent manner.
Main Results:
- TMPRSS4 directly converts inactive pro-uPA into its active form via its proteolytic activity.
- The active TMPRSS4 protease domain is released from cells and associates with the plasma membrane.
- TMPRSS4 enhances pro-uPA-mediated invasion in a manner dependent on its serine proteolytic activity.
Conclusions:
- TMPRSS4 acts as an upstream regulator of pro-uPA activation.
- The proteolytic activity of TMPRSS4 is crucial for mediating cancer cell invasion.
- This study provides key insights into the proteolytic function of TMPRSS4 and invasion control mechanisms.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic...
PI3K/mTOR/AKT Signaling Pathway
MAPK Signaling Cascades

